System and method to regulate ultrafiltration

Patent metadata

Field	Value
Publication number	US-9399091-B2
Application number	US-57112709-A
Country	US
Kind code	B2
Filing date	Sep 30, 2009
Priority date	Sep 30, 2009
Publication date	Jul 26, 2016
Grant date	Jul 26, 2016

Abstract

A medical device system including a physiological sensor and ultrafiltration unit senses a physiological signal in a patient and computes a fluid status measurement of the patient using the physiological signal. Ultrafiltration therapy is delivered to the patient according to a therapy delivery control parameter established in response to the fluid status measurement.

First claim

What is claimed is:

1. A medical monitoring system, comprising:
an implantable medical device comprising one or more sensors for sensing at least two different physiological signals in a patient;
a processor configured to receive the physiological signals and compute at least two different fluid status measurements of the patient using each of the at least two different physiological signals; wherein at least one of the physiological signals is an ECG signal;
an external therapy delivery device for delivering ultrafiltration therapy to the patient according to a therapy delivery control parameter; and
a controller configured to receive the at least two different fluid status measurements and establish a setting for the control parameter in response to the fluid status measurements;
a memory storing a target range of the fluid status measurements, wherein the target range is an index computed using a combination of the at least two different fluid status measurements;
the controller further configured to compare each of the fluid status measurements to the target range and automatically establish the control parameter in response to the comparison that readjusts an ultrafiltration level or an ultrafiltration pump flow rate.

2. The system of claim 1 wherein the processor is further configured to determine a trend of previously computed fluid status measurements and compute the target range using the trend.

3. The system of claim 1 wherein the control parameter corresponds to a flow rate and the controller is further configured to establish the control parameter in proportion to a difference between the fluid status measurements and the target range.

4. The system of claim 1 wherein the memory storing a target level of the fluid status measurements, the processor, the controller and the ultrafiltration therapy delivery device configured to operate cooperatively to perform ultrafiltration until a current fluid status measurement reaches the target level.

5. The system of claim 1 further comprising a memory storing a therapy delivery threshold;
the processor further configured to compare the fluid status measurement to the therapy delivery threshold and detect a need for ultrafiltration therapy in response to the comparison;
the controller being further configured to enable the ultrafiltration therapy delivery device in response to detecting the need.

6. The system of claim 1 wherein the controller is further configured to receive an updated fluid status measurement during delivery of ultrafiltration therapy and to determine an adjusted setting for the control parameter in response to the updated fluid status measurement.

7. The system of claim 1 wherein the controller is an implantable unit and the controller and the therapy delivery device are configured for wireless communication.

8. The system of claim 1 wherein the implantable medical device further comprises a telemetry module and the processor is an implantable processor implemented in the implantable medical device;
the controller being an external device in bidirectional telemetric communication with the implantable medical device.

9. The system of claim 1 further comprising a memory for logging an ultrafiltration therapy session delivered by the therapy delivery device according to the established control parameter.

10. The system of claim 1 , wherein the external therapy delivery device delivers therapy to a therapy delivery threshold based on comparing the fluid status measurement to the therapy delivery threshold.

11. The system of claim 10 , wherein the implantable sensor detects a need for ultrafiltration therapy in response to the comparison and enables the therapy delivery device in response to detecting the need.

12. The system of claim 1 , wherein the processor is configured to receive the physiological signals and compute at least two volume status measurements of the patient using each of the at least two different physiological signals; and
the controller configured to receive the at least two volume status measurements and establish a setting for the control parameter in response to the volume status measurements;
a memory storing a target range of the volume status measurements, wherein the target range is an index computed using a combination of the at least two volume status measurements;
the controller further configured to compare each of the volume status measurements to the target range and automatically establish the control parameter in response to the comparison.

13. The system of claim 12 wherein at least one of the at least two different physiological signals are selected from the group consisting of intraventricular pressure, thoracic impedance, oxygen, blood urea nitrogen, serum creatine, serum electrolytes, blood glucose, thyroid stimulating hormone, or any combination thereof.

14. The system of claim 1 wherein the at least two different physiological signals include at least one signal selected from the group consisting of intracardiac right ventricular pressure signals, and transthoracic signals.

15. The system of claim 1 , wherein the processor is configured to receive the physiological signals and compute at least one volume status measurement of the patient and at least one fluid status measurement of the patient using each of the at least two physiological signals; and
the controller configured to receive the at least one fluid status measurement and at least one volume status measurement and establish a setting for the control parameter in response to the fluid status measurement and the volume status measurement;
a memory storing a target range of the fluid status measurement and the volume status measurement, wherein the target range is an index computed using a combination of the at least one fluid status measurement and at least one volume status measurement;
the controller further configured to compare each of the fluid status measurement and the volume status measurement to the target range and automatically establish the control parameter in response to the comparison.

16. The system of claim 1 further comprising a display unit to show either the fluid status measurements, the difference between the fluid status measurements and the target range, or both.

17. The system of claim 1 further comprising an audio or visual alert if a fluid status measurement differs from the target range by a predetermined amount.

18. A medical monitoring system, comprising:
an implantable medical device comprising a sensor sensing at least two different physiological signals in a patient;
a processor configured to receive each of the physiological signals and compute at least two different fluid status measurement of the patient using each of the at least two different physiological signals; wherein at least one of the physiological signals is an ECG signal;
an external therapy delivery device for delivering ultrafiltration therapy to the patient according to a therapy delivery control parameter; and
a controller configured to receive the at least two different fluid status measurements and establish a setting for the control parameter in response to the fluid status measurements
wherein the processor is further configured to determine a trend of previously computed fluid status measurements and compute the target range using the trend, wherein the target range is an index computed using a combination of the at least two different fluid status measurements; that readjusts an ultrafiltration level or an ultrafiltration pump flow rate.

Assignees

• Sigg Daniel C
• Audet Sarah Anne
• Bennett Tommy D
• Warkentin Dwight H
• Medtronic Inc

Inventors

• Sigg Daniel C
• Audet Sarah Anne
• Bennett Tommy D
• Warkentin Dwight H

Classifications

• A61M2230/04

  Heartbeat characteristics, e.g. ECG, blood pressure modulation · CPC title

• A61M2205/3344

  Measuring or controlling pressure at the body treatment site · CPC title

• A61M1/3669

  Electrical impedance measurement of body fluids; transducers specially adapted therefor · CPC title

• A61M1/16

  with membranes · CPC title

• A61M2205/3523

  using telemetric means · CPC title